Inhibition of p53 Tumor Suppressor by Viral Interferon Regulatory Factor

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Virology

• Publication date

  2001-08-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JVI.75.16.7572-7582.2001PMID 11462029PMCID PMC114992
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of p300 Histone Acetyltransferase by Viral Interferon Regulatory Factor

  2000influential reference
• Surfing the p53 network

  2000influential reference
• Adenovirus E1B 55-Kilodalton Oncoprotein Inhibits p53 Acetylation by PCAF

  2000influential reference
• Functional Analysis of Human Herpesvirus 8-Encoded Viral Interferon Regulatory Factor 1 and Its Association with Cellular Interferon Regulatory Factors and p300

  1999cited by this paper
• Covalent and noncovalent modifiers of the p53 protein

  1999influential reference
• The p53 pathway

  1999influential reference
• Three unrelated viral transforming proteins (vIRF, EBNA2, and E1A) induce the MYC oncogene through the interferon-responsive PRF element by using different transcription coadaptors.

  1999cited by this paper
• The p53 paradox in the pathogenesis of tumor progression.

  1999cited by this paper
• p53 mutation spectrum and load: the generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer.

  1999cited by this paper
• p53 Sites Acetylated In Vitro by PCAF and p300 Are Acetylated In Vivo in Response to DNA Damage

  1999influential reference
• Mechanisms of p53-mediated apoptosis

  1999cited by this paper
• Reversal of p53‐induced cell‐cycle arrest

  1999cited by this paper
• Mutant p53: Gain-of-Function Oncoproteins and Wild-Type p53 Inactivators

  1999cited by this paper
• Human Herpesvirus 8 Encodes an Interferon Regulatory Factor (IRF) Homolog That Represses IRF-1-Mediated Transcription

  1998cited by this paper
• Enhanced phosphorylation of p53 by ATM in response to DNA damage.

  1998cited by this paper
• A simplified system for generating recombinant adenoviruses.

  1998cited by this paper
• Kaposi’s Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor

  1998cited by this paper
• p21/p53, cellular growth control and genomic integrity.

  1998cited by this paper
• New HPV E6 binding proteins: dangerous liaisons?

  1998cited by this paper
• DNA damage activates p53 through a phosphorylation-acetylation cascade.

  1998influential reference
• KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway

  1997cited by this paper
• Interferons and Other Cytokines

  1997cited by this paper
• Astronomers Tame a Workhorse Laser

  1996cited by this paper
• Molecular Mimicry of Human Cytokine and Cytokine Response Pathway Genes by KSHV

  1996influential reference
• Lytic growth of Kaposi's sarcoma–associated herpesvirus (human herpesvirus 8) in culture

  1996cited by this paper
• Blockage by Adenovirus E4orf6 of Transcriptional Activation by the p53 Tumor Suppressor

  1996influential reference
• AIDS-associated Kaposi's sarcoma

  1995cited by this paper
• Adenoviral ElA-associated protein p300 as a functional homologue of the transcriptional co-activator CBP

  1995cited by this paper
• Tumor suppressor p53 is a direct transcriptional activator of the human bax gene.

  1995influential reference
• Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas.

  1995cited by this paper
• Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

  1994cited by this paper
• Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.

  1994cited by this paper
• Potential role of human cytomegalovirus and p53 interaction in coronary restenosis.

  1994cited by this paper
• Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma.

  1993cited by this paper
• WAF1, a potential mediator of p53 tumor suppression.

  1993influential reference
• Regulation of Apoptosis by the Transforming Genes of the DNA Tumor Virus Adenovirus

  1993influential reference
• Interaction of the human papillomavirus type 16 E6 oncoprotein with wild-type and mutant human p53 proteins

  1992cited by this paper
• Definition of a consensus binding site for p53

  1992cited by this paper
• Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses.

  1991cited by this paper
• Domains required for in vitro association between the cellular p53 and the adenovirus 2 E1B 55K proteins.

  1990influential reference
• Human cells contain a DNA-activated protein kinase that phosphorylates simian virus 40 T antigen, mouse p53, and the human Ku autoantigen

  1990cited by this paper
• The p53 tumour suppressor protein is phosphorylated at serine 389 by casein kinase II.

  1990cited by this paper
• Association of human papillomavirus types 16 and 18 E6 proteins with p53.

  1990cited by this paper
• The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53.

  1990cited by this paper
• The p53 tumor suppressor gene and gene product.

  1989cited by this paper
• Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells.

  1979cited by this paper
• T antigen is bound to a host protein in SY40-transformed cells

  1979cited by this paper

• Kaposi’s Sarcoma: A Non-Communicable Outcome Mainly Prompted by Communicable Diseases in Sub-Saharan Africa

  2025cites this paper
• Unraveling the Kaposi Sarcoma-Associated Herpesvirus (KSHV) Lifecycle: An Overview of Latency, Lytic Replication, and KSHV-Associated Diseases

  2025cites this paper
• HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus

  2024cites this paper
• Discovery of amino acid-conjugated dimethylcardamonin analogues as potent anti-cervical cancer agents on SiHa cells targeting p53 signalling pathway.

  2024cites this paper
• The ORF45 Protein of Kaposi’s Sarcoma-Associated Herpesvirus and Its Critical Role in the Viral Life Cycle

  2022cites this paper
• A viral interferon regulatory factor degrades RNA-binding protein hnRNP Q1 to enhance aerobic glycolysis via recruiting E3 ubiquitin ligase KLHL3 and decaying GDPD1 mRNA

  2022cites this paper
• The Role of Viruses in Carcinogenesis and Molecular Targeting: From Infection to Being a Component of the Tumor Microenvironment

  2021cites this paper
• Proximity Biotin Labeling Reveals Kaposi’s Sarcoma-Associated Herpesvirus Interferon Regulatory Factor Networks

  2021cites this paper
• The ORF45 Protein of Kaposi Sarcoma-Associated Herpesvirus Is an Inhibitor of p53 Signaling during Viral Reactivation

  2021cites this paper
• The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV

  2021cites this paper
• Novel Functions and Virus-Host Interactions Implicated in Pathogenesis and Replication of Human Herpesvirus 8.

  2021cites this paper
• Proteomic approaches to investigate gammaherpesvirus biology and associated tumorigenesis.

  2021cites this paper
• Metabolic Control by DNA Tumor Virus-Encoded Proteins

  2021cites this paper
• An oncogenic viral interferon regulatory factor upregulates CUB domain-containing protein 1 to promote angiogenesis by hijacking transcription factor lymphoid enhancer-binding factor 1 and metastasis suppressor CD82

  2020cites this paper
• An oncogenic viral interferon regulatory factor upregulates CUB domain-containing protein 1 to promote angiogenesis by hijacking transcription factor lymphoid enhancer-binding factor 1 and metastasis suppressor CD82

  2020cites this paper
• Comparative analysis of the viral interferon regulatory factors of KSHV for their requisite for virus production and inhibition of the type I interferon pathway.

  2020cites this paper
• Role of Angiopoietins in Development of Cancer and Neoplasia Associated with Viral Infection

  2020cites this paper
• Proximity Biotin Labeling Reveals KSHV Interferon Regulatory Factor Networks

  2020cites this paper
• The Alterations of Cellular Signaling Pathways in the Host Cell upon the High Pathogenic Coronaviruses Infection, SARS-CoV and MERS-CoV. What Could Be Expected from the SARS-CoV-2?

  2020cites this paper
• Molecular Virology of KSHV in the Lymphocyte Compartment—Insights From Patient Samples and De Novo Infection Models

  2020cites this paper
• USP7-Dependent Regulation of TRAF Activation and Signaling by a Viral Interferon Regulatory Factor Homologue

  2019cites this paper
• Oncogenic Viral Protein Interactions with p53 Family Proteins

  2019cites this paper
• Oncogenic KSHV-encoded interferon regulatory factor upregulates HMGB2 and CMPK1 expression to promote cell invasion by disrupting a complex lncRNA-OIP5-AS1/miR-218-5p network

  2019cites this paper
• Importance of Promyelocytic Leukema Protein (PML) for Kaposi’s Sarcoma-Associated Herpesvirus Lytic Replication

  2018cites this paper
• Human Herpesvirus 8 Interferon Regulatory Factors 1 and 3 Mediate Replication and Latency Activities via Interactions with USP7 Deubiquitinase

  2018cites this paper
• Human Oncoviruses and p53 Tumor Suppressor Pathway Deregulation at the Origin of Human Cancers

  2018cites this paper
• Signal Transduction Pathways Associated with KSHV-Related Tumors.

  2018cites this paper
• p53 mediated IFN-β signaling to affect viral replication upon TGEV infection.

  2018cites this paper
• Contribution of the KSHV and EBV lytic cycles to tumourigenesis

  2018cites this paper
• Kaposi's Sarcoma-Associated Herpesvirus (KSHV/HHV8)

  2017cites this paper
• Rhadinoviral interferon regulatory factor homologues

  2017cites this paper
• Kaposi sarcoma herpesvirus pathogenesis

  2017cites this paper
• Epidemiological aspects and origin of KSHV

  2017cites this paper
• Kaposi's Sarcoma-Associated Herpesvirus MicroRNAs Target GADD45B To Protect Infected Cells from Cell Cycle Arrest and Apoptosis

  2016cites this paper
• Lesson from Viral Interferon Regulatory Factors

  2016cites this paper
• Identification of Kaposi Sarcoma Herpesvirus (KSHV) vIRF1 Protein as a Novel Interaction Partner of Human Deubiquitinase USP7*

  2016cites this paper
• The Functional Nucleus

  2016cites this paper
• Manipulation of PML Nuclear Bodies and DNA Damage Responses by DNA Viruses

  2016cites this paper
• Oncogenic Herpesvirus Utilizes Stress-Induced Cell Cycle Checkpoints for Efficient Lytic Replication

  2016cites this paper
• Viral modulation of host cell anti-apoptotic mechanisms and cellular stress to promote viral pathogenesis

  2016cites this paper
• A Rhesus Rhadinovirus Viral Interferon (IFN) Regulatory Factor Is Virion Associated and Inhibits the Early IFN Antiviral Response

  2015cites this paper
• KSHV latent protein LANA2 inhibits sumo2 modification of p53

  2015cites this paper
• The effects of the fungicides fenhexamid and myclobutanil on SH-SY5Y and U-251 MG human cell lines.

  2014cites this paper
• Molecular biology of human herpesvirus 8: novel functions and virus-host interactions implicated in viral pathogenesis and replication.

  2014cites this paper
• Structural proteins of Kaposi’s sarcoma-associated herpesvirus antagonize p53-mediated apoptosis

  2014cites this paper
• Human viral oncogenesis: a cancer hallmarks analysis.

  2014cites this paper
• p53 Tumor Suppressor Protein Stability and Transcriptional Activity Are Targeted by Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral Interferon Regulatory Factor 3

  2013cites this paper
• Distinct Roles of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral Interferon Regulatory Factors in Inflammatory Response and Cancer

  2013cites this paper
• The crystal structure of the DNA-binding domain of vIRF-1 from the oncogenic KSHV reveals a conserved fold for DNA binding and reinforces its role as a transcription factor

  2013cites this paper
• Review of latent and lytic phase biomarkers in Kaposi's sarcoma.

  2013cites this paper
• Small and large-scale gene regulation in Kaposi's Sarcoma-associated Herpesvirus

  2013cites this paper
• production inducing lytic replication of human herpesvirus 8 while blocking virus The targeting of primary effusion lymphoma cells for apoptosis by

  2013cites this paper
• Human Herpesvirus 8 Interferon Regulatory Factor-Mediated BH3-Only Protein Inhibition via Bid BH3-B Mimicry

  2012cites this paper
• Modulation of Immune System by Kaposi’s Sarcoma-Associated Herpesvirus: Lessons from Viral Evasion Strategies

  2012cites this paper
• iArc monogrAphs on the evAluAtion oF cArcinogenic risks to humAns

  2012cites this paper
• The Viral Interferon Regulatory Factors of Kaposi's Sarcoma-Associated Herpesvirus Differ in Their Inhibition of Interferon Activation Mediated by Toll-Like Receptor 3

  2012cites this paper
• DNA viruses and the cellular DNA-damage response.

  2012cites this paper
• KAPOSI SARCOMA HERPESVIRUS Kaposi sarcoma herpesvirus was considered by a previous

  2012cites this paper
• Viral Interferon Regulatory Factor 1 of Kaposi’s Sarcoma-Associated Herpesvirus Interacts with a Translocation Liposarcoma Protein-Associated Serine-Arginine Protein

  2012cites this paper
• Rhesus rhadinovirus vIRF R12 disrupts the PML- nuclear body via proteasome-dependent protein degradation pathway

  2012cites this paper
• Virus-Mediated Cell Proliferation

  2012cites this paper
• Viral Interferon Regulatory Factors Are Critical for Delay of the Host Immune Response against Rhesus Macaque Rhadinovirus Infection

  2011cites this paper
• Mechanism and consequences of interferon γ inhibition by the viral interferon regulatory factor 3 (vIRF-3) of Kaposi’s sarcoma-associated herpesvirus (KSHV)

  2011cites this paper
• Viral interferon regulatory factors inhibit the immune response following rhesus rhadinovirus infection

  2011cites this paper
• The Viral Interferon Regulatory Factors of KSHV: Immunosuppressors or Oncogenes?

  2011influential citation
• Cooperation between Viral Interferon Regulatory Factor 4 and RTA To Activate a Subset of Kaposi's Sarcoma-Associated Herpesvirus Lytic Promoters

  2011cites this paper
• Interactomics identifies novel regulators of the IRF-1 tumour suppressor protein

  2011cites this paper
• Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis.

  2010cites this paper
• Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis.

  2010cites this paper
• Why do viruses cause cancer? Highlights of the first century of human tumour virology

  2010cites this paper
• Salmonella typhimurium infection increases p53 acetylation in intestinal epithelial cells.

  2010cites this paper
• Bim Nuclear Translocation and Inactivation by Viral Interferon Regulatory Factor

  2010cites this paper
• Sarcoma de Kaposi en trasplante renal, respuesta a sirolimus: reporte de caso y revisión de la literatura científica

  2010cites this paper
• KSHV Immune Evasion

  2009cites this paper
• Molecular Mechanisms of Viral Immune Evasion Proteins to Inhibit MHC Class I Antigen Processing and Presentation

  2009cites this paper
• Regulation of Expression, Mode of Action and Downstream Targets of ORF50 Protein in KSHV Lytic Cycle Activation

  2009cites this paper
• Viral Interferon Regulatory Factors

  2009cites this paper
• Kaposi’s Sarcoma-Associated Herpesvirus

  2009cites this paper
• Autocrine and Paracrine Promotion of Cell Survival and Virus Replication by Human Herpesvirus 8 Chemokines

  2008cites this paper
• Immune evasion in Kaposi's sarcoma-associated herpes virus associated oncogenesis.

  2008cites this paper
• In vivo growth-restricted and reversible malignancy induced by Human Herpesvirus-8/ KSHV: a cell and animal model of virally induced Kaposi's sarcoma

  2008cites this paper
• The biology of Kaposi’s sarcoma-associated herpesvirus and the infection of human immunodeficiency virus

  2008cites this paper
• Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 3 stabilizes hypoxia-inducible factor-1 alpha to induce vascular endothelial growth factor expression.

  2008cites this paper
• Kaposi's Sarcoma-Associated Herpesvirus K-Cyclin Interacts with Cdk9 and Stimulates Cdk9-Mediated Phosphorylation of p53 Tumor Suppressor

  2007cites this paper
• Immune evasion by Kaposi's sarcoma-associated herpesvirus

  2007cites this paper
• Kaposi's sarcoma: a model of both malignancy and chronic inflammation.

  2007cites this paper
• In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma.

  2007cites this paper
• The IRF family, revisited.

  2007cites this paper
• AIDS-ASSOCIATED VIRAL ONCOGENESIS Cancer Treatment and Research

  2007cites this paper
• Modulation of cell signaling pathways by kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8)

  2007cites this paper
• Molecular biology of KSHV in relation to AIDS-associated oncogenesis.

  2007cites this paper
• Kaposi sarcoma after kidney transplantation.

  2007cites this paper
• Identification of the DNA Sequence Interacting with Kaposi's Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor 1

  2007cites this paper
• Kaposi sarcoma herpesvirus-encoded interferon regulator factors.

  2007influential citation
• Newly Identified Human Herpesviruses: HHV-6, HHV-7, and HHV-8

  2007cites this paper
• Functions of the vFLIP protein of KSHV

  2007cites this paper
• Reactivation and lytic replication of EBV

  2007cites this paper
• Inhibition of Interferon Signaling by the Kaposi's Sarcoma-Associated Herpesvirus Full-Length Viral Interferon Regulatory Factor 2 Protein

  2006cites this paper
• Inhibition of the ATM/p53 Signal Transduction Pathway by Kaposi's Sarcoma-Associated Herpesvirus Interferon Regulatory Factor 1

  2006cites this paper
• Transcriptome profiling the gills of amoebic gill disease (AGD)-affected Atlantic salmon (Salmo salar L.): a role for tumor suppressor p53 in AGD pathogenesis?

  2006influential citation